Skip to Content
Merck
CN
  • Purification of an endogenous inhibitor of L-Dopa decarboxylase activity from human serum.

Purification of an endogenous inhibitor of L-Dopa decarboxylase activity from human serum.

Neurochemical research (2005-09-24)
Alice-Georgia Vassiliou, Dido Vassilacopoulou, Emmanuel G Fragoulis
ABSTRACT

An endogenous inhibitor of L-Dopa decarboxylase was identified and purified from human serum. In Triton X-114 partitioning experiments, the inhibitor was recovered in the detergent enriched phase, suggesting a hydrophobic nature. Purification was achieved by means of proteinase K digestion, ammonium sulphate precipitation, phenyl sepharose hydrophobic chromatography and subsequent extraction from a nondenaturing polyacrylamide gel. This purification scheme resulted in the isolation of a single 25 kDa band, bearing L-Dopa decarboxylase inhibitory activity. The purified molecule was found to be resistant to heat and digestion by various proteases. Proteolytic digestion of the purified inhibitor by pronase and aminopeptidase M was achieved only following carboxymethylation. The biological importance of the presence of an L-Dopa decarboxylase activity inhibitor in normal biological fluids remains to be elucidated. The better understanding of the regulation of Ddc enzymatic activity could prove valuable in the clarification of the enzyme's role in a series of pathological conditions, as well as, in physiological regulatory mechanisms.

MATERIALS
Product Number
Brand
Product Description

Supelco
Levodopa, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
3,4-Dihydroxy-L-phenylalanine, ≥98% (TLC)
Sigma-Aldrich
3,4-Dihydroxy-L-phenylalanine, Vetec, reagent grade, 98%